214 related articles for article (PubMed ID: 24116381)
1. Involvement of midkine in neuroblastoma tumourigenesis.
Kishida S; Kadomatsu K
Br J Pharmacol; 2014 Feb; 171(4):896-904. PubMed ID: 24116381
[TBL] [Abstract][Full Text] [Related]
2. Midkine promotes neuroblastoma through Notch2 signaling.
Kishida S; Mu P; Miyakawa S; Fujiwara M; Abe T; Sakamoto K; Onishi A; Nakamura Y; Kadomatsu K
Cancer Res; 2013 Feb; 73(4):1318-27. PubMed ID: 23243020
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of midkine as the basis of its pharmacological effects.
Muramatsu T
Br J Pharmacol; 2014 Feb; 171(4):814-26. PubMed ID: 23992440
[TBL] [Abstract][Full Text] [Related]
4. The midkine family of growth factors: diverse roles in nervous system formation and maintenance.
Winkler C; Yao S
Br J Pharmacol; 2014 Feb; 171(4):905-12. PubMed ID: 24125182
[TBL] [Abstract][Full Text] [Related]
5. The expression and function of midkine in the vertebrate retina.
Gramage E; Li J; Hitchcock P
Br J Pharmacol; 2014 Feb; 171(4):913-23. PubMed ID: 24460673
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer.
Güngör C; Hofmann BT; Wolters-Eisfeld G; Bockhorn M
Br J Pharmacol; 2014 Feb; 171(4):849-58. PubMed ID: 24024905
[TBL] [Abstract][Full Text] [Related]
7. Midkine as a regulator of B cell survival in health and disease.
Cohen S; Shachar I
Br J Pharmacol; 2014 Feb; 171(4):888-95. PubMed ID: 24111754
[TBL] [Abstract][Full Text] [Related]
8. Midkine: an emerging target of drug development for treatment of multiple diseases.
Muramatsu T; Kadomatsu K
Br J Pharmacol; 2014 Feb; 171(4):811-3. PubMed ID: 24460672
[TBL] [Abstract][Full Text] [Related]
9. Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives.
Herradón G; Pérez-García C
Br J Pharmacol; 2014 Feb; 171(4):837-48. PubMed ID: 23889475
[TBL] [Abstract][Full Text] [Related]
10. The role of midkine in skeletal remodelling.
Liedert A; Schinke T; Ignatius A; Amling M
Br J Pharmacol; 2014 Feb; 171(4):870-8. PubMed ID: 24102259
[TBL] [Abstract][Full Text] [Related]
11. Midkine and multiple sclerosis.
Takeuchi H
Br J Pharmacol; 2014 Feb; 171(4):931-5. PubMed ID: 24460675
[TBL] [Abstract][Full Text] [Related]
12. Midkine in repair of the injured nervous system.
Yoshida Y; Sakakima H; Matsuda F; Ikutomo M
Br J Pharmacol; 2014 Feb; 171(4):924-30. PubMed ID: 24460674
[TBL] [Abstract][Full Text] [Related]
13. Midkine in host defence.
Gela A; Jovic S; Nordin SL; Egesten A
Br J Pharmacol; 2014 Feb; 171(4):859-69. PubMed ID: 24024937
[TBL] [Abstract][Full Text] [Related]
14. Midkine in nephrogenesis, hypertension and kidney diseases.
Sato W; Sato Y
Br J Pharmacol; 2014 Feb; 171(4):879-87. PubMed ID: 24106831
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action.
Lorente M; Torres S; Salazar M; Carracedo A; Hernández-Tiedra S; Rodríguez-Fornés F; García-Taboada E; Meléndez B; Mollejo M; Campos-Martín Y; Lakatosh SA; Barcia J; Guzmán M; Velasco G
Cell Death Differ; 2011 Jun; 18(6):959-73. PubMed ID: 21233844
[TBL] [Abstract][Full Text] [Related]
16. Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition.
Reiff T; Huber L; Kramer M; Delattre O; Janoueix-Lerosey I; Rohrer H
Development; 2011 Nov; 138(21):4699-708. PubMed ID: 21989914
[TBL] [Abstract][Full Text] [Related]
17. Plasma midkine level is a prognostic factor for human neuroblastoma.
Ikematsu S; Nakagawara A; Nakamura Y; Ohira M; Shinjo M; Kishida S; Kadomatsu K
Cancer Sci; 2008 Oct; 99(10):2070-4. PubMed ID: 19016768
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of midkine contributes to anti-apoptotic effects in human meningiomas.
Tong Y; Mentlein R; Buhl R; Hugo HH; Krause J; Mehdorn HM; Held-Feindt J
J Neurochem; 2007 Feb; 100(4):1097-107. PubMed ID: 17181554
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of midkine in cardiovascular disease.
Kadomatsu K; Bencsik P; Görbe A; Csonka C; Sakamoto K; Kishida S; Ferdinandy P
Br J Pharmacol; 2014 Feb; 171(4):936-44. PubMed ID: 24286213
[TBL] [Abstract][Full Text] [Related]
20. Midkine lacking its last 40 amino acids acts on endothelial and neuroblastoma tumor cells and inhibits tumor development.
Dianat N; Le Viet B; Gobbo E; Auger N; Bièche I; Bennaceur-Griscelli A; Griscelli F
Mol Cancer Ther; 2015 Jan; 14(1):213-24. PubMed ID: 25492619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
